Hepatitis A and typhoid vaccine

From WikiProjectMed
(Redirected from ViATIM)
Jump to navigation Jump to search
Hepatitis A and typhoid vaccine
Combination of
Hepatitis AVaccine
TyphoidVaccine
Names
Trade namesViVaxim, Hepatyrix, ViATIM
Clinical data
Pregnancy
category
  • AU: B2
Routes of
use
Intramuscular injection
External links
AHFS/Drugs.comUK Drug Information
Legal
Legal status
  • AU: S4 (Prescription only)
Identifiers
CAS Number
  • 827024-58-8 checkY
ChemSpider
  • none
ATC code

Hepatitis A and typhoid vaccine is a combination vaccine to protect against hepatitis A and typhoid.[1]

Formulation

It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria.

Society and culture

Brand names

The vaccine is distributed under various brand names in the European Union.[1] Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]

References

  1. 1.0 1.1 1.2 1.3 List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) (PDF) (Report). European Medicines Agency (EMA). Archived (PDF) from the original on 19 October 2020. Retrieved 18 October 2020.
  2. "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Archived (PDF) from the original on 15 July 2018. Retrieved 15 July 2018.
  3. "VIVAXIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  4. "Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine" (PDF). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
  5. "Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine". Archived from the original on 19 October 2020. Retrieved 18 October 2020.
  6. "Vivaxim 1mL injection syringe composite pack". Therapeutic Goods Administration (TGA). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
  7. "Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack" (PDF). Therapeutic Goods Administration (TGA). Retrieved 18 October 2020.{{cite web}}: CS1 maint: url-status (link)
  8. "ViATIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
  9. "ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 3 September 2019. Archived from the original on 19 October 2020. Retrieved 18 October 2020.